Version history

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n## Overview\n\n\n```mermaid\nflowchart TD\n    TGF[\"TGF\"] -->|\"participates in\"| senescence[\"senescence\"]\n    TGF[\"TGF\"] -->|\"activates\"| TNF[\"TNF\"]\n    TGF[\"TGF\"] -->|\"participates in\"| unfolded_protein_response[\"unfolded protein response\"]\n    TGF[\"TGF\"] -->|\"participates in\"| TGF_beta_signaling[\"TGF-beta signaling\"]\n    TGF[\"TGF\"] -->|\"participates in\"| neurotrophin_signaling[\"neurotrophin signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| endothelial_cells[\"endothelial cells\"]\n    TGF[\"TGF\"] -->|\"supports\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| NF_kB_signaling[\"NF-kB signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| microglia[\"microglia\"]\n    TGF[\"TGF\"] -->|\"participates in\"| oxidative_stress_response[\"oxidative stress response\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| astrocytes[\"astrocytes\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| epigenetic_regulation[\"epigenetic regulation\"]\n    TGF[\"TGF\"] -->|\"participates in\"| Wnt_signaling[\"Wnt signaling\"]\n    style TGF fill:#4fc3f7,stroke:#333,color:#000\n```\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-beta</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-beta superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-beta1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-beta (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-beta1, TGF-beta2, and TGF-beta3. In the nervous system, TGF-beta signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-beta signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving TGF-β (Transforming Growth Factor Beta) discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    IL_10[\"IL-10\"] -->|\"activates\"| TGF[\"TGF\"]\n    ROS[\"ROS\"] -->|\"activates\"| TGF[\"TGF\"]\n    BDNF[\"BDNF\"] -->|\"activates\"| TGF[\"TGF\"]\n    DNA[\"DNA\"] -->|\"activates\"| TGF[\"TGF\"]\n    RNA[\"RNA\"] -.->|\"inhibits\"| TGF[\"TGF\"]\n    SMAD3[\"SMAD3\"] -.->|\"inhibits\"| TGF[\"TGF\"]\n    RNA[\"RNA\"] -->|\"regulates\"| TGF[\"TGF\"]\n    HDAC[\"HDAC\"] -->|\"activates\"| TGF[\"TGF\"]\n    IL_6[\"IL-6\"] -->|\"activates\"| TGF[\"TGF\"]\n    IL_10[\"IL-10\"] -->|\"biomarker for\"| TGF[\"TGF\"]\n    CREB[\"CREB\"] -->|\"activates\"| TGF[\"TGF\"]\n    HIF[\"HIF\"] -->|\"activates\"| TGF[\"TGF\"]\n    GDNF[\"GDNF\"] -->|\"activates\"| TGF[\"TGF\"]\n    ARG1[\"ARG1\"] -->|\"activates\"| TGF[\"TGF\"]\n    EGFR[\"EGFR\"] -->|\"expressed in\"| TGF[\"TGF\"]\n    style IL_10 fill:#ce93d8,stroke:#333,color:#000\n    style TGF fill:#ce93d8,stroke:#333,color:#000\n    style ROS fill:#ce93d8,stroke:#333,color:#000\n    style BDNF fill:#ce93d8,stroke:#333,color:#000\n    style DNA fill:#ce93d8,stroke:#333,color:#000\n    style RNA fill:#ce93d8,stroke:#333,color:#000\n    style SMAD3 fill:#ce93d8,stroke:#333,color:#000\n    style HDAC fill:#ce93d8,stroke:#333,color:#000\n    style IL_6 fill:#ce93d8,stroke:#333,color:#000\n    style CREB fill:#ce93d8,stroke:#333,color:#000\n    style HIF fill:#ce93d8,stroke:#333,color:#000\n    style GDNF fill:#ce93d8,stroke:#333,color:#000\n    style ARG1 fill:#ce93d8,stroke:#333,color:#000\n    style EGFR fill:#ce93d8,stroke:#333,color:#000\n```\n\n",
  "entity_type": "protein"
}

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n## Overview\n\n\nflowchart TD\n    TGF[\"TGF\"] -->|\"participates in\"| senescence[\"senescence\"]\n    TGF[\"TGF\"] -->|\"activates\"| TNF[\"TNF\"]\n    TGF[\"TGF\"] -->|\"participates in\"| unfolded_protein_response[\"unfolded protein response\"]\n    TGF[\"TGF\"] -->|\"participates in\"| TGF_beta_signaling[\"TGF-beta signaling\"]\n    TGF[\"TGF\"] -->|\"participates in\"| neurotrophin_signaling[\"neurotrophin signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| endothelial_cells[\"endothelial cells\"]\n    TGF[\"TGF\"] -->|\"supports\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| NF_kB_signaling[\"NF-kB signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| microglia[\"microglia\"]\n    TGF[\"TGF\"] -->|\"participates in\"| oxidative_stress_response[\"oxidative stress response\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| astrocytes[\"astrocytes\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| epigenetic_regulation[\"epigenetic regulation\"]\n    TGF[\"TGF\"] -->|\"participates in\"| Wnt_signaling[\"Wnt signaling\"]\n    style TGF fill:#4fc3f7,stroke:#333,color:#000\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-beta</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-beta superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-beta1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-beta (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-beta1, TGF-beta2, and TGF-beta3. In the nervous system, TGF-beta signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-beta signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n\n## Pathway Diagram\n\nThe following diagram shows the key molecular relationships involving TGF-β (Transforming Growth Factor Beta) discovered through SciDEX knowledge graph analysis:\n\n```mermaid\ngraph TD\n    IL_10[\"IL-10\"] -->|\"activates\"| TGF[\"TGF\"]\n    ROS[\"ROS\"] -->|\"activates\"| TGF[\"TGF\"]\n    BDNF[\"BDNF\"] -->|\"activates\"| TGF[\"TGF\"]\n    DNA[\"DNA\"] -->|\"activates\"| TGF[\"TGF\"]\n    RNA[\"RNA\"] -.->|\"inhibits\"| TGF[\"TGF\"]\n    SMAD3[\"SMAD3\"] -.->|\"inhibits\"| TGF[\"TGF\"]\n    RNA[\"RNA\"] -->|\"regulates\"| TGF[\"TGF\"]\n    HDAC[\"HDAC\"] -->|\"activates\"| TGF[\"TGF\"]\n    IL_6[\"IL-6\"] -->|\"activates\"| TGF[\"TGF\"]\n    IL_10[\"IL-10\"] -->|\"biomarker for\"| TGF[\"TGF\"]\n    CREB[\"CREB\"] -->|\"activates\"| TGF[\"TGF\"]\n    HIF[\"HIF\"] -->|\"activates\"| TGF[\"TGF\"]\n    GDNF[\"GDNF\"] -->|\"activates\"| TGF[\"TGF\"]\n    ARG1[\"ARG1\"] -->|\"activates\"| TGF[\"TGF\"]\n    EGFR[\"EGFR\"] -->|\"expressed in\"| TGF[\"TGF\"]\n    style IL_10 fill:#ce93d8,stroke:#333,color:#000\n    style TGF fill:#ce93d8,stroke:#333,color:#000\n    style ROS fill:#ce93d8,stroke:#333,color:#000\n    style BDNF fill:#ce93d8,stroke:#333,color:#000\n    style DNA fill:#ce93d8,stroke:#333,color:#000\n    style RNA fill:#ce93d8,stroke:#333,color:#000\n    style SMAD3 fill:#ce93d8,stroke:#333,color:#000\n    style HDAC fill:#ce93d8,stroke:#333,color:#000\n    style IL_6 fill:#ce93d8,stroke:#333,color:#000\n    style CREB fill:#ce93d8,stroke:#333,color:#000\n    style HIF fill:#ce93d8,stroke:#333,color:#000\n    style GDNF fill:#ce93d8,stroke:#333,color:#000\n    style ARG1 fill:#ce93d8,stroke:#333,color:#000\n    style EGFR fill:#ce93d8,stroke:#333,color:#000\n```\n\n",
  "entity_type": "protein"
}

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n## Overview\n\n\nflowchart TD\n    TGF[\"TGF\"] -->|\"participates in\"| senescence[\"senescence\"]\n    TGF[\"TGF\"] -->|\"activates\"| TNF[\"TNF\"]\n    TGF[\"TGF\"] -->|\"participates in\"| unfolded_protein_response[\"unfolded protein response\"]\n    TGF[\"TGF\"] -->|\"participates in\"| TGF_beta_signaling[\"TGF-beta signaling\"]\n    TGF[\"TGF\"] -->|\"participates in\"| neurotrophin_signaling[\"neurotrophin signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| endothelial_cells[\"endothelial cells\"]\n    TGF[\"TGF\"] -->|\"supports\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| NF_kB_signaling[\"NF-kB signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| microglia[\"microglia\"]\n    TGF[\"TGF\"] -->|\"participates in\"| oxidative_stress_response[\"oxidative stress response\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| astrocytes[\"astrocytes\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| epigenetic_regulation[\"epigenetic regulation\"]\n    TGF[\"TGF\"] -->|\"participates in\"| Wnt_signaling[\"Wnt signaling\"]\n    style TGF fill:#4fc3f7,stroke:#333,color:#000\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-beta</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-beta superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-beta1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-beta (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-beta1, TGF-beta2, and TGF-beta3. In the nervous system, TGF-beta signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-beta signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n",
  "entity_type": "protein"
}

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n## Overview\n\n\nflowchart TD\n    TGF[\"TGF\"] -->|\"participates in\"| senescence[\"senescence\"]\n    TGF[\"TGF\"] -->|\"activates\"| TNF[\"TNF\"]\n    TGF[\"TGF\"] -->|\"participates in\"| unfolded_protein_response[\"unfolded protein response\"]\n    TGF[\"TGF\"] -->|\"participates in\"| TGF_beta_signaling[\"TGF-beta signaling\"]\n    TGF[\"TGF\"] -->|\"participates in\"| neurotrophin_signaling[\"neurotrophin signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| endothelial_cells[\"endothelial cells\"]\n    TGF[\"TGF\"] -->|\"supports\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| NF_kB_signaling[\"NF-kB signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| microglia[\"microglia\"]\n    TGF[\"TGF\"] -->|\"participates in\"| oxidative_stress_response[\"oxidative stress response\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| astrocytes[\"astrocytes\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| epigenetic_regulation[\"epigenetic regulation\"]\n    TGF[\"TGF\"] -->|\"participates in\"| Wnt_signaling[\"Wnt signaling\"]\n    style TGF fill:#4fc3f7,stroke:#333,color:#000\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-β</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-β superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-β1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-β (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-β1, TGF-β2, and TGF-β3. In the nervous system, TGF-β signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-β signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n",
  "entity_type": "protein"
}

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n## Overview\n\n\n```mermaid\nflowchart TD\n    TGF[\"TGF\"] -->|\"participates in\"| senescence[\"senescence\"]\n    TGF[\"TGF\"] -->|\"activates\"| TNF[\"TNF\"]\n    TGF[\"TGF\"] -->|\"participates in\"| unfolded_protein_response[\"unfolded protein response\"]\n    TGF[\"TGF\"] -->|\"participates in\"| TGF_beta_signaling[\"TGF-beta signaling\"]\n    TGF[\"TGF\"] -->|\"participates in\"| neurotrophin_signaling[\"neurotrophin signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| endothelial_cells[\"endothelial cells\"]\n    TGF[\"TGF\"] -->|\"supports\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| NF_kB_signaling[\"NF-kB signaling\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| microglia[\"microglia\"]\n    TGF[\"TGF\"] -->|\"participates in\"| oxidative_stress_response[\"oxidative stress response\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| astrocytes[\"astrocytes\"]\n    TGF[\"TGF\"] -->|\"expressed in\"| stem_cells[\"stem cells\"]\n    TGF[\"TGF\"] -->|\"participates in\"| epigenetic_regulation[\"epigenetic regulation\"]\n    TGF[\"TGF\"] -->|\"participates in\"| Wnt_signaling[\"Wnt signaling\"]\n    style TGF fill:#4fc3f7,stroke:#333,color:#000\n```\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-β</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-β superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-β1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-β (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-β1, TGF-β2, and TGF-β3. In the nervous system, TGF-β signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-β signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n",
  "entity_type": "protein"
}

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n## Overview\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-β</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-β superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-β1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-β (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-β1, TGF-β2, and TGF-β3. In the nervous system, TGF-β signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-β signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n",
  "entity_type": "protein"
}

{
  "content_md": "## Overview\n\n<table class=\"infobox infobox-protein\">\n  <tr>\n    <th class=\"infobox-header\" colspan=\"2\">TGF-β</th>\n  </tr>\n  <tr>\n    <td class=\"label\">Symbol</td>\n    <td><strong>TGFB1/2/3</strong></td>\n  </tr>\n  <tr>\n    <td class=\"label\">Full Name</td>\n    <td>Transforming Growth Factor Beta</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Protein Family</td>\n    <td>TGF-β superfamily</td>\n  </tr>\n  <tr>\n    <td class=\"label\">Type</td>\n    <td>Cytokine / Growth factor</td>\n  </tr>\n  <tr>\n    <td class=\"label\">UniProt</td>\n    <td><a href=\"https://www.uniprot.org/uniprot/P01137\" target=\"_blank\">P01137 (TGF-β1)</a></td>\n  </tr>\n  <tr>\n    <td class=\"label\">KG Connections</td>\n    <td><a href=\"/atlas\" style=\"color:#4fc3f7\">View in Atlas</a></td>\n  </tr>\n</table>\n\n**TGF-β (Transforming Growth Factor Beta)** is a multifunctional cytokine superfamily that regulates cell growth, differentiation, immune responses, and tissue homeostasis. In mammals, the family consists of three highly homologous isoforms: TGF-β1, TGF-β2, and TGF-β3. In the nervous system, TGF-β signaling plays critical roles in neuronal survival, glial activation, blood-brain barrier integrity, neuroinflammation, and tissue repair following injury. Dysregulation of TGF-β signaling is implicated in multiple neurological disorders including Alzheimer's disease, stroke, multiple sclerosis, and brain tumors.\n\n## Structure and Activation\n\nTGF-β proteins are synthesized as large precursor molecules that undergo proteolytic processing. The mature TGF-β is a 25 kDa homodimeric protein secreted in a latent form bound to latency-associated peptide (LAP). Activation requires release from this latent complex through:\n\n- Proteolytic cleavage by enzymes like plasmin or matrix metalloproteinases (MMPs)\n- Conformational changes induced by integrins (particularly αvβ6 and αvβ8)\n- pH changes or reactive oxygen species\n\nOnce activated, TGF-β binds to type II serine/threonine kinase receptors (TGFβRII), which recruit and phosphorylate type I receptors (TGFβRI/ALK5), initiating downstream signaling.\n\n## Signaling Pathways\n\n### Canonical SMAD Pathway\n\nThe primary TGF-β signaling cascade:\n1. Activated TGFβRI phosphorylates SMAD2 and SMAD3 (receptor-SMADs)\n2. Phosphorylated SMAD2/3 bind SMAD4 (co-SMAD)\n3. The SMAD complex translocates to nucleus\n4. Regulates transcription of target genes (plasminogen activator inhibitor-1, collagens, fibronectin, etc.)\n5. SMAD7 acts as negative feedback inhibitor\n\n### Non-Canonical Pathways\n\nTGF-β also activates SMAD-independent signaling:\n- **MAPK pathways**: ERK, JNK, p38 activation\n- **PI3K/AKT**: Cell survival signaling\n- **Rho GTPases**: Cytoskeletal regulation\n- **TAK1/NF-κB**: Inflammatory responses\n\n## Functions in the Nervous System\n\n### Neurodevelopment\n\nDuring CNS development, TGF-β regulates:\n- Neural stem cell proliferation and differentiation\n- Neuronal migration\n- Axon guidance\n- Synaptogenesis\n- Myelination by oligodendrocytes\n\nTGF-β2 and TGF-β3 are particularly important for neurogenesis and neural crest development.\n\n### Neuroprotection\n\nTGF-β1 exhibits neuroprotective properties:\n- Promotes neuronal survival under stress conditions\n- Reduces excitotoxic damage\n- Enhances expression of anti-apoptotic factors\n- Stimulates production of neurotrophic factors (BDNF, NGF)\n\n### Blood-Brain Barrier Maintenance\n\nTGF-β signaling in endothelial cells and pericytes maintains BBB integrity by:\n- Upregulating tight junction proteins (claudins, occludin)\n- Reducing vascular permeability\n- Suppressing inflammatory activation of endothelium\n\nLoss of TGF-β signaling causes BBB breakdown and cerebrovascular dysfunction.\n\n### Immune Regulation and Neuroinflammation\n\nTGF-β is a master regulator of CNS immunity:\n- Maintains microglia in a quiescent, surveillant state\n- Suppresses pro-inflammatory cytokine production\n- Promotes M2 (anti-inflammatory) microglial polarization\n- Regulates astrocyte reactivity\n- Controls T cell infiltration into CNS\n\nHowever, chronic TGF-β activation can also promote fibrosis and glial scarring after injury.\n\n## Role in Neurological Disease\n\n### Alzheimer's Disease\n\nIn [Alzheimer's disease](/diseases/alzheimers-disease), TGF-β has complex, context-dependent roles:\n- **Protective**: Promotes microglial clearance of amyloid-beta\n- **Detrimental**: Excessive signaling may impair Aβ clearance and promote tau phosphorylation\n- Reduced TGF-β signaling associated with increased amyloid deposition in some models\n- Polymorphisms in TGF-β1 gene associated with AD risk\n\n### Stroke and Ischemic Injury\n\nFollowing ischemic stroke:\n- TGF-β1 levels increase acutely in peri-infarct regions\n- Promotes angiogenesis and tissue remodeling\n- Reduces neuroinflammation in subacute phase\n- Excessive late-phase TGF-β contributes to glial scarring\n- TGF-β blockade in chronic phase may improve functional recovery\n\n### Multiple Sclerosis\n\nIn [multiple sclerosis](/diseases/multiple-sclerosis):\n- Reduced TGF-β signaling associated with disease progression\n- TGF-β1 suppresses autoreactive T cells and promotes regulatory T cells (Tregs)\n- Enhances remyelination by promoting oligodendrocyte precursor differentiation\n- Therapeutic potential of TGF-β pathway activation\n\n### Glioblastoma\n\nIn brain tumors, particularly glioblastoma:\n- TGF-β promotes tumor invasion and angiogenesis\n- Creates immunosuppressive tumor microenvironment\n- Associated with poor prognosis\n- TGF-β inhibitors being explored as anti-cancer therapy\n\n### Cerebral Amyloid Angiopathy (CAA)\n\nTGF-β1 regulates cerebrovascular amyloid clearance. Genetic variants in TGF-β pathway genes influence CAA severity and hemorrhagic stroke risk.\n\n## Therapeutic Targeting\n\n### TGF-β Inhibitors\n\nMultiple approaches to block excessive TGF-β signaling:\n- **Neutralizing antibodies** (fresolimumab)\n- **Small molecule receptor kinase inhibitors** (galunisertib, LY2157299)\n- **Antisense oligonucleotides**\n- Being tested primarily in cancer and fibrotic diseases\n\n### TGF-β Activation/Enhancement\n\nFor neurodegenerative diseases with deficient TGF-β signaling:\n- SMAD pathway activators\n- Delivery of recombinant TGF-β\n- Gene therapy approaches\n\nThe challenge is achieving appropriate context-specific modulation, as TGF-β effects are highly cell-type and disease-stage dependent.\n\n## Related Entities\n\n- [SMAD Proteins](/proteins/smad) - Primary downstream signaling effectors\n- [Microglia](/cell-types/microglia) - Key CNS cell type regulated by TGF-β\n- [Blood-Brain Barrier](/anatomy/blood-brain-barrier) - Structure maintained by TGF-β\n- [Neuroinflammation](/mechanisms/neuroinflammation) - Process modulated by TGF-β\n- [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease with complex TGF-β involvement\n- [Astrocytes](/cell-types/astrocytes) - Glial cells that produce and respond to TGF-β\n\n## References\n\n1. Wyss-Coray T, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. *Nat Med*. 2001;7(5):612-618.\n2. Dobolyi A, et al. The neuroprotective functions of transforming growth factor beta proteins. *Int J Mol Sci*. 2012;13(7):8219-8258.\n3. Brionne TC, et al. Loss of TGF-β signaling in neurons modifies plaques in a mouse model of Alzheimer's disease. *Circ Res*. 2003;92(11):1123-1129.\n4. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. *Neurotherapeutics*. 2016;13(4):685-701.\n5. Massagué J. TGFβ signalling in context. *Nat Rev Mol Cell Biol*. 2012;13(10):616-630.\n\n## External Links\n\n- [UniProt: TGF-β1](https://www.uniprot.org/uniprot/P01137)\n- [KEGG: TGF-beta signaling pathway](https://www.genome.jp/pathway/map04350)\n- [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)\n- [PubMed: TGF-beta neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=TGF-beta+neurodegeneration)\n",
  "entity_type": "protein"
}

{
  "content_md": "# TGF-β (Transforming Growth Factor Beta)\n\n**TGF-β** (Transforming Growth Factor Beta) is a multifunctional cytokine superfamily involved in cellular processes including proliferation, differentiation, apoptosis, and immune regulation.\n\n## Role in Neurodegeneration\n\nTGF-β signaling has been implicated in:\n- Neuroinflammation regulation\n- Blood-brain barrier integrity\n- Microglial activation\n- Protein aggregation clearance\n\n## Related Wiki Pages\n\nSearch the wiki for \"TGF-beta\" to find related therapeutic strategies and mechanisms.\n\n---\n*This is a stub page. Content will be expanded as research progresses.*\n",
  "entity_type": "protein"
}